Evaxion presents preclinical data on AML vaccine candidate
AI Summary
Evaxion has presented preclinical data on a vaccine candidate targeting acute myeloid leukemia (AML), advancing its research in immunotherapy treatments for cancer.
Evaxion has presented preclinical data on a vaccine candidate targeting acute myeloid leukemia (AML), advancing its research in immunotherapy treatments for cancer.
Kathmandu Post —
Kathmandu Post —
Science Daily —
Medical Xpress —
Vanguard Nigeria —
The Straits Times —